The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism (Q46587398)

23 December 2017

title

The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism (English)

1 reference

23 December 2017

0 references

1 reference

3

1 reference

23 December 2017

author name string

Johanna Hilli

1

1 reference

23 December 2017

Tuomas Korhonen

2

1 reference

23 December 2017

Juho Hokkanen

4

1 reference

23 December 2017

Sampo Mattila

5

1 reference

23 December 2017

Kari Laine

6

1 reference

23 December 2017

publication date

19 May 2008

1 reference

23 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

48

1 reference

23 December 2017

page(s)

986-994

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Assessment of CYP1A2 activity in clinical practice: why, how, and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Gastrointestinal and systemic uptake of bismuth in mice after oral exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Metabolism of 17 alpha-ethynylestradiol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Clinical pharmacokinetics of fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Effect of oral contraceptives on plasma clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Increased bioavailability of oral melatonin after fluvoxamine coadministration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizoph

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Consumption of charcoal-broiled meat as an experimental tool for discerning CYP1A2-mediated drug metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Coffee, CYP1A2 genotype, and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

How important are gender differences in pharmacokinetics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

The influence of sex on pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318669

21 January 2018

Identifiers

DOI

10.1177/0091270008318669

1 reference

23 December 2017

PubMed ID

18490497

1 reference

23 December 2017